Leveraging Patient Data & Clinical Endpoints for Reverse Translation: Uncovering Efficacious Targets in Fibrotic Diseases
Time: 1:30 pm
day: Day One
Details:
- Examine how large-scale patient data sets can inform early-stage drug discovery and how to leverage these patient data sets to identify potential causative targets
- Highlighting the connection between functional endpoints and anti-fibrotic effects to understand which functional clinical endpoints are good surrogates for antifibrotic efficacy and targets with a higher probability of being associated with worse disease severity
